Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
Drug common name | ONAMETOSTAT |
INN | onametostat |
Description | Onametostat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target protein arginine N-methyltransferase 5. |
Classification | Small molecule |
Drug class | enzyme inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Nc1nc2cc(CC[C@H]3C[C@@H](n4ccc5c(N)ncnc54)[C@H](O)[C@@H]3O)ccc2cc1Br |
PDB | — |
CAS-ID | 2086772-26-9 |
RxCUI | — |
ChEMBL ID | CHEMBL4249337 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | N8VKI8FPW0 (ChemIDplus, GSRS) |